Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | pyruvate dehydrogenase | 0.0125 | 0.2756 | 0.9128 |
Onchocerca volvulus | 0.0048 | 0 | 0.5 | |
Echinococcus multilocularis | tumor protein p63 | 0.0327 | 1 | 1 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.0132 | 0.3019 | 0.5 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0054 | 0.0204 | 0.5 |
Brugia malayi | kinase, mitochondrial precursor | 0.0132 | 0.3019 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0132 | 0.3019 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0125 | 0.2756 | 0.9128 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.0132 | 0.3019 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0132 | 0.3019 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0102 | 0.1955 | 0.6475 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.0132 | 0.3019 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.